0001209191-13-047200.txt : 20131003
0001209191-13-047200.hdr.sgml : 20131003
20131003163833
ACCESSION NUMBER: 0001209191-13-047200
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131002
FILED AS OF DATE: 20131003
DATE AS OF CHANGE: 20131003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SafeStitch Medical, Inc.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
STREET 2: SUITE A-100
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 305-575-4600
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
STREET 2: SUITE A-100
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLATTERY JOSEPH P
CENTRAL INDEX KEY: 0001246530
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 131134223
MAIL ADDRESS:
STREET 1: C/O SAFESTITCH MEDICAL, INC.
STREET 2: 635 DAVID DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2013-10-02
0
0000876378
SafeStitch Medical, Inc.
SFES.OB
0001246530
SLATTERY JOSEPH P
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
EVP and CFO
Series B Convertible Stock
0.40
Series B Convertible Stock
250000
I
Held by Reporting Person and Spouse, as JTWROS
On September 17, 2013, SafeStitch Medical, Inc. (the "Issuer") sold and issued to the Reporting Person and his spouse, as JTWROS, in a privately negotiated transaction pursuant to a securities purchase agreement, an aggregate of 25,000 shares of the Issuer's Series B convertible preferred stock at a purchase price of $4.00 per share. Upon the filing of an Amended and Restated Certificate of Incorporation by the Issuer with the State of Delaware, each share of the Issuer's Series B convertible preferred stock will automatically convert into ten (10) shares of the Issuer's common stock.
The Series B Preferred Stock has no expiration date.
Joseph P. Slattery
2013-10-03